Table 1.
Participant characteristics and evaluation results
| Total (n = 47) | Fall group (n = 22) | Non-fall group (n = 25) | p value | |
|---|---|---|---|---|
| Men/women1 | 21/26 | 7/15 | 14/11 | 0.143 |
| Age, years2 | 80.7±6.3 | 82.5±6.1 | 79.2±6.1 | 0.075 |
| Duration of AD, months3 | 28 (2–144) | 18 (2–132) | 34 (3–144) | 0.564 |
| Education, years3 | 6 (0–10) | 6 (0–10) | 6 (3–10) | 0.352 |
| Complications3 | 6 (0–35) | 7 (0–35) | 5 (1–27) | 0.487 |
| Types of oral medicines3 | 5 (1–12) | 5 (1–11) | 5 (1–12) | 0.889 |
| MMSE-J, points2 | 16.3±5.6 | 15.9±5.6 | 16.7±5.6 | 0.623 |
| NPI, points3 | 6 (0–40) | 6 (0–39) | 6 (0–40) | 0.723 |
| FIM, points2 | 96.2±14.5 | 92.5±17.7 | 99.4±10.3 | 0.113 |
Data are presented as number of persons, mean ± standard deviation, or median (range), as appropriate. AD, Alzheimer's disease; MMSE-J, Japanese version of Mini-Mental State Examination; NPI, Neuropsychiatric Inventory; FIM, Functional Independence Measure.
1
Fisher's exact test.
2
Welch's t test.
3
Mann-Whitney U test.